The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Poractant Alfa Market Research Report 2024
Synopsis
Poractant Alfa is a natural extract, phospholipids account for 90% of the dry weight, most of which are phosphatidyl choline (PC), the PC with surface activity is phosphatidyl choline dipalmitic acid, the rest of the phospholipids also include phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol and sphingomyelin.In addition, there are two kinds of sp-b and sp-c, which show the active substance (PS) specific proteins.Porcine pneumophylline injection for the treatment and prevention of respiratory distress syndrome (RDS) in premature infants.
The global Poractant Alfa market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Poractant Alfa is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Poractant Alfa is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Poractant Alfa include Chiesi, Douglas Pharma, Takeda, Mylan and Piramal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Poractant Alfa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poractant Alfa.
Report Scope
The Poractant Alfa market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poractant Alfa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poractant Alfa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi
Douglas Pharma
Takeda
Mylan
Piramal
Segment by Type
Rapid Dosing
Microdosing
Segment by Application
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poractant Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poractant Alfa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Poractant Alfa is a natural extract, phospholipids account for 90% of the dry weight, most of which are phosphatidyl choline (PC), the PC with surface activity is phosphatidyl choline dipalmitic acid, the rest of the phospholipids also include phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol and sphingomyelin.In addition, there are two kinds of sp-b and sp-c, which show the active substance (PS) specific proteins.Porcine pneumophylline injection for the treatment and prevention of respiratory distress syndrome (RDS) in premature infants.
The global Poractant Alfa market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Poractant Alfa is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Poractant Alfa is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Poractant Alfa include Chiesi, Douglas Pharma, Takeda, Mylan and Piramal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Poractant Alfa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poractant Alfa.
Report Scope
The Poractant Alfa market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poractant Alfa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poractant Alfa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi
Douglas Pharma
Takeda
Mylan
Piramal
Segment by Type
Rapid Dosing
Microdosing
Segment by Application
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poractant Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poractant Alfa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Poractant Alfa Market Overview
1.1 Product Overview and Scope of Poractant Alfa
1.2 Poractant Alfa Segment by Type
1.2.1 Global Poractant Alfa Market Value Comparison by Type (2024-2030)
1.2.2 Rapid Dosing
1.2.3 Microdosing
1.3 Poractant Alfa Segment by Application
1.3.1 Global Poractant Alfa Market Value by Application: (2024-2030)
1.3.2 Salvage Treatment
1.3.3 Prevention of Respiratory Distress Syndrome (RDS)
1.4 Global Poractant Alfa Market Size Estimates and Forecasts
1.4.1 Global Poractant Alfa Revenue 2019-2030
1.4.2 Global Poractant Alfa Sales 2019-2030
1.4.3 Global Poractant Alfa Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poractant Alfa Market Competition by Manufacturers
2.1 Global Poractant Alfa Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poractant Alfa Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poractant Alfa Average Price by Manufacturers (2019-2024)
2.4 Global Poractant Alfa Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poractant Alfa, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poractant Alfa, Product Type & Application
2.7 Poractant Alfa Market Competitive Situation and Trends
2.7.1 Poractant Alfa Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poractant Alfa Players Market Share by Revenue
2.7.3 Global Poractant Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poractant Alfa Retrospective Market Scenario by Region
3.1 Global Poractant Alfa Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poractant Alfa Global Poractant Alfa Sales by Region: 2019-2030
3.2.1 Global Poractant Alfa Sales by Region: 2019-2024
3.2.2 Global Poractant Alfa Sales by Region: 2025-2030
3.3 Global Poractant Alfa Global Poractant Alfa Revenue by Region: 2019-2030
3.3.1 Global Poractant Alfa Revenue by Region: 2019-2024
3.3.2 Global Poractant Alfa Revenue by Region: 2025-2030
3.4 North America Poractant Alfa Market Facts & Figures by Country
3.4.1 North America Poractant Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poractant Alfa Sales by Country (2019-2030)
3.4.3 North America Poractant Alfa Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Poractant Alfa Market Facts & Figures by Country
3.5.1 Europe Poractant Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poractant Alfa Sales by Country (2019-2030)
3.5.3 Europe Poractant Alfa Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poractant Alfa Market Facts & Figures by Country
3.6.1 Asia Pacific Poractant Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poractant Alfa Sales by Country (2019-2030)
3.6.3 Asia Pacific Poractant Alfa Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Poractant Alfa Market Facts & Figures by Country
3.7.1 Latin America Poractant Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poractant Alfa Sales by Country (2019-2030)
3.7.3 Latin America Poractant Alfa Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poractant Alfa Market Facts & Figures by Country
3.8.1 Middle East and Africa Poractant Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poractant Alfa Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poractant Alfa Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poractant Alfa Sales by Type (2019-2030)
4.1.1 Global Poractant Alfa Sales by Type (2019-2024)
4.1.2 Global Poractant Alfa Sales by Type (2025-2030)
4.1.3 Global Poractant Alfa Sales Market Share by Type (2019-2030)
4.2 Global Poractant Alfa Revenue by Type (2019-2030)
4.2.1 Global Poractant Alfa Revenue by Type (2019-2024)
4.2.2 Global Poractant Alfa Revenue by Type (2025-2030)
4.2.3 Global Poractant Alfa Revenue Market Share by Type (2019-2030)
4.3 Global Poractant Alfa Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poractant Alfa Sales by Application (2019-2030)
5.1.1 Global Poractant Alfa Sales by Application (2019-2024)
5.1.2 Global Poractant Alfa Sales by Application (2025-2030)
5.1.3 Global Poractant Alfa Sales Market Share by Application (2019-2030)
5.2 Global Poractant Alfa Revenue by Application (2019-2030)
5.2.1 Global Poractant Alfa Revenue by Application (2019-2024)
5.2.2 Global Poractant Alfa Revenue by Application (2025-2030)
5.2.3 Global Poractant Alfa Revenue Market Share by Application (2019-2030)
5.3 Global Poractant Alfa Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chiesi
6.1.1 Chiesi Corporation Information
6.1.2 Chiesi Description and Business Overview
6.1.3 Chiesi Poractant Alfa Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chiesi Poractant Alfa Product Portfolio
6.1.5 Chiesi Recent Developments/Updates
6.2 Douglas Pharma
6.2.1 Douglas Pharma Corporation Information
6.2.2 Douglas Pharma Description and Business Overview
6.2.3 Douglas Pharma Poractant Alfa Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Douglas Pharma Poractant Alfa Product Portfolio
6.2.5 Douglas Pharma Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Poractant Alfa Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Poractant Alfa Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Poractant Alfa Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Poractant Alfa Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Corporation Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Poractant Alfa Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Piramal Poractant Alfa Product Portfolio
6.5.5 Piramal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poractant Alfa Industry Chain Analysis
7.2 Poractant Alfa Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poractant Alfa Production Mode & Process
7.4 Poractant Alfa Sales and Marketing
7.4.1 Poractant Alfa Sales Channels
7.4.2 Poractant Alfa Distributors
7.5 Poractant Alfa Customers
8 Poractant Alfa Market Dynamics
8.1 Poractant Alfa Industry Trends
8.2 Poractant Alfa Market Drivers
8.3 Poractant Alfa Market Challenges
8.4 Poractant Alfa Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Poractant Alfa Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Poractant Alfa Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Poractant Alfa Market Competitive Situation by Manufacturers in 2023
Table 4. Global Poractant Alfa Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Poractant Alfa Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Poractant Alfa Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Poractant Alfa Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Poractant Alfa Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Poractant Alfa, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Poractant Alfa, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Poractant Alfa, Product Type & Application
Table 12. Global Key Manufacturers of Poractant Alfa, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Poractant Alfa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poractant Alfa as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Poractant Alfa Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Poractant Alfa Sales by Region (2019-2024) & (K Doses)
Table 18. Global Poractant Alfa Sales Market Share by Region (2019-2024)
Table 19. Global Poractant Alfa Sales by Region (2025-2030) & (K Doses)
Table 20. Global Poractant Alfa Sales Market Share by Region (2025-2030)
Table 21. Global Poractant Alfa Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Poractant Alfa Revenue Market Share by Region (2019-2024)
Table 23. Global Poractant Alfa Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Poractant Alfa Revenue Market Share by Region (2025-2030)
Table 25. North America Poractant Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Poractant Alfa Sales by Country (2019-2024) & (K Doses)
Table 27. North America Poractant Alfa Sales by Country (2025-2030) & (K Doses)
Table 28. North America Poractant Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Poractant Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Poractant Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Poractant Alfa Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Poractant Alfa Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Poractant Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Poractant Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Poractant Alfa Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Poractant Alfa Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Poractant Alfa Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Poractant Alfa Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Poractant Alfa Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Poractant Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Poractant Alfa Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Poractant Alfa Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Poractant Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Poractant Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Poractant Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Poractant Alfa Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Poractant Alfa Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Poractant Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Poractant Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Poractant Alfa Sales (K Doses) by Type (2019-2024)
Table 51. Global Poractant Alfa Sales (K Doses) by Type (2025-2030)
Table 52. Global Poractant Alfa Sales Market Share by Type (2019-2024)
Table 53. Global Poractant Alfa Sales Market Share by Type (2025-2030)
Table 54. Global Poractant Alfa Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Poractant Alfa Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Poractant Alfa Revenue Market Share by Type (2019-2024)
Table 57. Global Poractant Alfa Revenue Market Share by Type (2025-2030)
Table 58. Global Poractant Alfa Price (US$/Dose) by Type (2019-2024)
Table 59. Global Poractant Alfa Price (US$/Dose) by Type (2025-2030)
Table 60. Global Poractant Alfa Sales (K Doses) by Application (2019-2024)
Table 61. Global Poractant Alfa Sales (K Doses) by Application (2025-2030)
Table 62. Global Poractant Alfa Sales Market Share by Application (2019-2024)
Table 63. Global Poractant Alfa Sales Market Share by Application (2025-2030)
Table 64. Global Poractant Alfa Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Poractant Alfa Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Poractant Alfa Revenue Market Share by Application (2019-2024)
Table 67. Global Poractant Alfa Revenue Market Share by Application (2025-2030)
Table 68. Global Poractant Alfa Price (US$/Dose) by Application (2019-2024)
Table 69. Global Poractant Alfa Price (US$/Dose) by Application (2025-2030)
Table 70. Chiesi Corporation Information
Table 71. Chiesi Description and Business Overview
Table 72. Chiesi Poractant Alfa Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Chiesi Poractant Alfa Product
Table 74. Chiesi Recent Developments/Updates
Table 75. Douglas Pharma Corporation Information
Table 76. Douglas Pharma Description and Business Overview
Table 77. Douglas Pharma Poractant Alfa Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Douglas Pharma Poractant Alfa Product
Table 79. Douglas Pharma Recent Developments/Updates
Table 80. Takeda Corporation Information
Table 81. Takeda Description and Business Overview
Table 82. Takeda Poractant Alfa Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Takeda Poractant Alfa Product
Table 84. Takeda Recent Developments/Updates
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Poractant Alfa Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Mylan Poractant Alfa Product
Table 89. Mylan Recent Developments/Updates
Table 90. Piramal Corporation Information
Table 91. Piramal Description and Business Overview
Table 92. Piramal Poractant Alfa Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Piramal Poractant Alfa Product
Table 94. Piramal Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Poractant Alfa Distributors List
Table 98. Poractant Alfa Customers List
Table 99. Poractant Alfa Market Trends
Table 100. Poractant Alfa Market Drivers
Table 101. Poractant Alfa Market Challenges
Table 102. Poractant Alfa Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Poractant Alfa
Figure 2. Global Poractant Alfa Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Poractant Alfa Market Share by Type in 2023 & 2030
Figure 4. Rapid Dosing Product Picture
Figure 5. Microdosing Product Picture
Figure 6. Global Poractant Alfa Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Poractant Alfa Market Share by Application in 2023 & 2030
Figure 8. Salvage Treatment
Figure 9. Prevention of Respiratory Distress Syndrome (RDS)
Figure 10. Global Poractant Alfa Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Poractant Alfa Market Size (2019-2030) & (US$ Million)
Figure 12. Global Poractant Alfa Sales (2019-2030) & (K Doses)
Figure 13. Global Poractant Alfa Average Price (US$/Dose) & (2019-2030)
Figure 14. Poractant Alfa Report Years Considered
Figure 15. Poractant Alfa Sales Share by Manufacturers in 2023
Figure 16. Global Poractant Alfa Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Poractant Alfa Players: Market Share by Revenue in 2023
Figure 18. Poractant Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Poractant Alfa Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Poractant Alfa Sales Market Share by Country (2019-2030)
Figure 21. North America Poractant Alfa Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Poractant Alfa Sales Market Share by Country (2019-2030)
Figure 25. Europe Poractant Alfa Revenue Market Share by Country (2019-2030)
Figure 26. Germany Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Poractant Alfa Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Poractant Alfa Revenue Market Share by Region (2019-2030)
Figure 33. China Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Poractant Alfa Sales Market Share by Country (2019-2030)
Figure 44. Latin America Poractant Alfa Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Poractant Alfa Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Poractant Alfa Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Poractant Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Poractant Alfa by Type (2019-2030)
Figure 54. Global Revenue Market Share of Poractant Alfa by Type (2019-2030)
Figure 55. Global Poractant Alfa Price (US$/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of Poractant Alfa by Application (2019-2030)
Figure 57. Global Revenue Market Share of Poractant Alfa by Application (2019-2030)
Figure 58. Global Poractant Alfa Price (US$/Dose) by Application (2019-2030)
Figure 59. Poractant Alfa Value Chain
Figure 60. Poractant Alfa Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
